Grand Brilliance Group Holdings Limited (HKG:8372)
Hong Kong · Delayed Price · Currency is HKD 0.1170
0.00 (0.00%)
Jul 17, 2025, 3:36 PM HKT
HKG:8372 Revenue
In the fiscal year ending March 31, 2025, Grand Brilliance Group Holdings had annual revenue of 94.45M HKD with 15.32% growth. Grand Brilliance Group Holdings had revenue of 52.76M in the half year ending March 31, 2025, with 20.80% growth.
Revenue
94.45M
Revenue Growth
+15.32%
P/S Ratio
0.99
Revenue / Employee
2.01M
Employees
47
Market Cap
93.60M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |